研究者業績

杉原 亨

スギハラ トオル  (Toru Sugihara)

基本情報

所属
自治医科大学 医学部腎泌尿器外科学講座  泌尿器科学部門 講師

J-GLOBAL ID
201801004267689389
researchmap会員ID
B000299299

研究キーワード

 1

学歴

 1

論文

 48
  • Kinoshita Y, Sugihara T, Yasunaga H, Matsui H, Ishikawa A, Fujimura T, Fukuhara H, Ishibashi Y, Fushimi K, Homma Y
    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2018年8月  査読有り
  • Daisuke Obinata, Toru Sugihara, Hideo Yasunaga, Junichi Mochida, Kenya Yamaguchi, Yasutaka Murata, Tsuyoshi Yoshizawa, Tsuyoshi Matsui, Hiroki Matsui, Yusuke Sasabuchi, Tetsuya Fujimura, Yukio Homma, Satoru Takahashi
    International journal of urology : official journal of the Japanese Urological Association 25(7) 655-659 2018年7月  査読有り
    OBJECTIVE: To compare nationwide outcomes of tension-free vaginal mesh surgery and laparoscopic sacrocolpopexy for the treatment of pelvic organ prolapse in Japan. METHODS: Using the Diagnosis Procedure Combination database, we collected data on female patients who underwent tension-free vaginal mesh surgery or laparoscopic sacrocolpopexy for pelvic organ prolapse from April 2014 to March 2015. We compared the proportion of perioperative adverse events, duration of anesthesia, total costs and postoperative length of stay between the groups. Univariate and multivariate analyses were carried out for age, comorbidity, mesh volume, additional concomitant surgery and hospital volume. RESULTS: We identified 3023 patients, including 2388 who underwent tension-free vaginal mesh surgery, and 635 who underwent laparoscopic sacrocolpopexy. The median age at the time of surgery was significantly higher in the tension-free vaginal mesh group (71 vs 66 years; P < 0.001). The tension-free vaginal mesh group had a higher proportion of all adverse events (7.1% vs 1.8%; P < 0.001) and a higher proportion of genitourinary complications (5.7% vs 1.1%; P < 0.001). The median duration of anesthesia was shorter in the tension-free vaginal mesh group (150 vs 286 min; P < 0.001). The total cost was significantly lower in the tension-free vaginal mesh group. CONCLUSIONS: Both procedures offer favorable results for surgical treatment of pelvic organ prolapse. Overall, the tension-free vaginal mesh procedure seems to represent a good option for high-risk women, such as elderly patients, whereas laparoscopic sacrocolpopexy is useful for younger patients with a higher level of sexual activity.
  • Yoshitaka Kinoshita, Akira Ishikawa, Konan Hara, Toru Sugihara, Yoshitaka Ishibashi, Yukio Homma
    Hemodialysis international. International Symposium on Home Hemodialysis 22(2) 176-179 2018年4月  査読有り
    INTRODUCTION: We hypothesized that presence of plasma cell neoplasms might be a risk for thrombosis of arteriovenous fistulas (AVFs) as well as other well-known factors including age, sex, race, and presence of diabetes mellitus or certain vascular disorders. METHODS: In this single-center, retrospective study based on medical record data, we investigated the influence of plasma cell neoplasms and the above-mentioned factors on the occurrence of complete occlusive thrombosis of the AVF within 30 days after surgery for creation of the AVF. Thrombosis was defined as the absence of bruit or thrill on auscultation and palpation, throughout systole and diastole. FINDINGS: We retrospectively assessed the medical records of 91 patients with end-stage renal failure, including 8 patients with plasma cell neoplasm (5 with multiple myeloma and 3 with amyloid light-chain amyloidosis), who underwent surgical creation of an AVF at the wrist or anatomical snuff box for the first time between April 2014 and December 2016. Early thrombosis (i.e., within 30 days of surgery) occurred in 50.0% (4/8) and 10.8% (9/83) of patients with and without plasma cell neoplasm, respectively (P = 0.013). Multivariate analysis revealed that, after adjusting for baseline characteristics, plasma cell neoplasm was the only significant risk factor for early AVF thrombosis (odds ratio, 38.8; 95% confidence interval, 4.0-378.9; P = 0.0017). DISCUSSION: Considering the poor prognosis of plasma cell neoplasm and its association with higher risk for AVF thrombosis, another type of vascular access is likely to be more suitable than AVF in such patients.
  • Yosuke Hirasawa, Makoto Ohori, Toru Sugihara, Takeshi Hashimoto, Naoya Satake, Tatsuo Gondo, Yoshihiro Nakagami, Kazunori Namiki, Kunihiko Yoshioka, Jun Nakashima, Masaaki Tachibana, Yoshio Ohno
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY 47(11) 1083-1089 2017年11月  査読有り
    To investigate the impact of the time interval (TI) between prostate biopsy and robot-assisted radical prostatectomy (RARP) on the risk of biochemical recurrence (BCR). We retrospectively reviewed the medical records of 793 consecutive patients who were treated with RARP at our institution. Patients were divided into three groups, according to TI, to compare BCR-free survival (BCRFS) rates: Group 1 (n = 196), TI &lt; 3 months; Group 2 (n = 513), 3 &lt;= TI &lt; 6 months; Group 3 (n = 84), TI &gt;= 6 months. Eighty-three patients with TI &gt;= 6 months were matched with an equal number of patients with TI &lt; 6 months based on propensity scores by using four preoperative factors: prostate-specific antigen (PSA), primary (pGS) and secondary (sGS) Gleason score and positive prostate biopsy. The 5-year BCRFS rates for TI Groups 1, 2, and 3 were 76%, 80.7% and 82.6% (P = 0.99), respectively. The multivariate analysis revealed that PSA, pGS, sGS and a positive prostate biopsy were independent preoperative risk factors for BCR. The propensity adjusted 5-year BCRFS for patients with TI &gt;= 6 months was 84.0%. This was not worse than that of patients with TI &lt; 6 months (71.0%, P = 0.18). In our cohorts, a delay in the time from biopsy to RARP did not significantly affect recurrence. Therefore, hasty treatment decisions are unnecessary for at least 6 months after diagnosis of early prostate cancer.
  • Yuta Yamada, Tetsuya Fujimura, Hiroshi Fukuhara, Toru Sugihara, Hideyo Miyazaki, Tohru Nakagawa, Haruki Kume, Yasuhiko Igawa, Yukio Homma
    INTERNATIONAL JOURNAL OF UROLOGY 24(10) 749-756 2017年10月  査読有り
    ObjectivesTo investigate predictors of continence outcomes after robot-assisted radical prostatectomy. MethodsClinical records of 272 patients who underwent robot-assisted radical prostatectomy were investigated. Preoperative Overactive Bladder Symptom Score, International Prostate Symptom Score and clinicopathological factors were investigated, and relationships between factors and recovery of continence after robot-assisted radical prostatectomy were assessed. The presence of overactive bladder was defined as having urgency for more than once a week and having 3 points according to the Overactive Bladder Symptom Score. ResultsAge (66 years) was significantly associated with continence within 6 months after robot-assisted radical prostatectomy (P = 0.033). The absence of overactive bladder and lower Overactive Bladder Symptom Score (&lt;3) were significantly associated with recovery of continence within 12 months after surgery (both variables P = 0.009). In terms of achieving recovery of continence after robot-assisted radical prostatectomy, Kaplan-Meier curves showed earlier recovery in age 66 years, prostate weight 40 g and overactive bladder symptom score &lt;3 (P = 0.0072, 0.0172 and 0.0140, respectively). Multivariate analysis showed that the presence of overactive bladder was an independent negative predictor for recovery of continence within 12 months after surgery (P = 0.019). ConclusionsThe presence of baseline overactive bladder seems to represent an independent negative predictor for recovery of continence at 12 months after robot-assisted radical prostatectomy.

MISC

 60